Refer A Patient

Request An Appointment

Ophthalmology

TEPEZZA

TEPEZZA (teprotumumab-trbw) is an insulin-like growth factor-1 receptor inhibitor used to treat Thyroid Eye Disease
Infusion or injection therapy referral
What it treats Thyroid Eye Disease (TED)
Prescribed by Ophthalmologists
How it’s administered Intravenous (IV) infusion
Frequency Once every three weeks for eight doses
Length of treatment About 90 minutes

About This Therapy

TEPEZZA (teprotumumab-trbw) is an insulin-like growth factor-1 receptor inhibitor used to treat Thyroid Eye Disease, an autoimmune disease characterized by proptosis (a condition where the eyes are pushed forward and bulge outward) leading to eye pain, double vision, and difficulty closing the eyelid.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

TEPEZZA REFERRAL FORM

TEPEZZA REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.
REFERRAL FORM →

Ready to refer a patient for TEPEZZA

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.